Triple negative breast cancer (TNBC) is a specific breast cancer subtype that is immunohistochemically negative for expressions of prognostic markers including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [1]. The gene discussed is ERBB2; the disease is breast carcinoma.